Gen1E Lifesciences
GEn1E’s p38 kinase inhibitor drugs treats Acute Respiratory Distress Syndrome (ARDS) - 67% of the critically ill COVID-19 patients had ARDS.
Rankings by
National Ranking400th
in United States Regional Ranking455th
in North America and Caribbean Global Ranking1083rd
worldwide